tirzepatide caremark In 2025, CVS excluded Zepbound from its primary formulary in favor of an exclusive positioning deal with rival Wegovy, restricting access for millions of covered patients. This latest shift effectively reverses 22% body weight 80% of US prescription claims
Pay in 4 interest-free payments of $6.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29




























